Lv4
577 积分 2021-02-19 加入
Advantages of Extended-Release Metformin in Patients with Type 2 Diabetes Mellitus
16小时前
已完结
Advantages of Extended-Release Metformin in Patients with Type 2 Diabetes Mellitus
16小时前
已关闭
Advantages of Extended-Release Metformin in Patients with Type 2 Diabetes Mellitus
16小时前
已关闭
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial
1个月前
已完结
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
1个月前
已完结
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
1个月前
已完结
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
1个月前
已完结
Biological, Radiological, and Clinical Significance of Spotty Calcification in Coronary Artery Disease
1个月前
已完结
Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis
2个月前
已完结
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
2个月前
已完结
皖公网安备34019202002308
